Patents by Inventor David Yee

David Yee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070028625
    Abstract: According to one aspect, a method of detecting catalyst module overheating in a catalytic combustion system is provided. In one example, the method includes detecting one or more signals from at least one probe adapted to obtain values associated with at least one of the outlet gas temperature of a catalyst module and the outlet face temperature of the catalyst module included in a catalytic combustor. The one or more signals are compared with a preselected value associated with catalyst overheating. The detected temperature may be detected over time to determine a rate of change in the temperature. The temperature may be detected with a UV sensor directed to the catalyst outlet face.
    Type: Application
    Filed: September 1, 2004
    Publication date: February 8, 2007
    Inventors: Ajay Joshi, David Yee
  • Publication number: 20060286093
    Abstract: Soluble, secreted tumor necrosis factor receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise one cysteine-rich repeat that is homologous to other tumor necrosis factor receptors, such as transmembrane activator and CAML-interactor (TACI). The polypeptides may be used for detecting ligands, agonists and antagonists. The polypeptides may also be used in methods that modulate B cell activation.
    Type: Application
    Filed: July 20, 2006
    Publication date: December 21, 2006
    Inventors: Jane Gross, Wenfeng Xu, Karen Madden, David Yee
  • Publication number: 20060067933
    Abstract: Soluble, secreted tumor necrosis factor receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise one cysteine-rich repeat that is homologous to other tumor necrosis factor receptors, such as transmembrane activator and CAML-interactor (TACI). The polypeptides may be used for detecting ligands, agonists and antagonists. The polypeptides may also be used in methods that modulate B cell activation.
    Type: Application
    Filed: August 10, 2005
    Publication date: March 30, 2006
    Inventors: Jane Gross, Wenfeng Xu, Karen Madden, David Yee
  • Publication number: 20050216471
    Abstract: A method for analyzing content on a web page. In one method embodiment, the present invention accesses a web page having content. Additionally, the web page is processed through a filter wherein the filter transfers the content of the web page to an analyzer. The analyzer analyzes the content of the web page. The analyzer then returns the result of the analyzing to the server which appends the result of the analyzing to the content of the web page. The results are then displayed on the web page. In so doing, the ability to provide an analysis of the functionality of a web page at the time of development is provided.
    Type: Application
    Filed: March 24, 2004
    Publication date: September 29, 2005
    Applicant: ORACLE INTERNATIONAL CORPORATION
    Inventors: David Yee, Peter Wallack, Hok-Min Lie
  • Publication number: 20050104575
    Abstract: An electric power meter (102) includes a temperature sensor (114) and a controller (112). The controller (112) is operable, based on the temperature reported from the temperature sensor (114), to generate alarm(s) when the temperature exceeds certain alarm threshold(s) (307, 507, 508) and to activate a power disconnect switch (104), thereby shutting off power to a customer premises, when the temperature exceeds a shut off threshold (309, 509). The controller (112) is operable to activate the power disconnect switch (104) for non-payment of electricity cost, subject to secondary criteria based on regulatory requirements. A customer terminal (103) may be used to notify a customer of an alarm condition, to provide information regarding electrical power usage or to provide information regarding disconnection of electrical power.
    Type: Application
    Filed: December 9, 2004
    Publication date: May 19, 2005
    Inventors: David Yee, Philip Zucarelli, Theodore Keller, David Wallis
  • Patent number: 6889337
    Abstract: A method for repeatable application testing on a computer system for audible output generated by the application in conjunction with a screen reader or similar assistive technology. The method includes recording user inputs to a user application using a test input component. The user inputs are also accessed by a screen reader input component. Outputs of the user application are recorded using a test output component. The outputs of the user application are also accessed by a screen reader output component. The resulting screen reader outputs are recorded and are analyzed with respect to the recorded user inputs and the recorded outputs of the user application. The user inputs to the user application can be keyboard inputs or mouse inputs, and inputs of other input devices. The outputs of the user application can be graphical outputs or alphanumeric outputs for a display of the computer system.
    Type: Grant
    Filed: June 3, 2002
    Date of Patent: May 3, 2005
    Assignee: Oracle International Corporation
    Inventor: David Yee
  • Publication number: 20040206091
    Abstract: According to one aspect, a method of controlling a multi-combustor catalytic combustion system is provided for determining a characteristic of a fuel-air mixture downstream of a preburner associated with a catalytic combustor and adjusting the fuel flow to the preburner based on the characteristic. The characteristic may include, for example, a measurement of the preburner or catalyst outlet temperature or a determination of the position of the homogeneous combustion wave in the burnout zone of the combustor.
    Type: Application
    Filed: January 16, 2004
    Publication date: October 21, 2004
    Inventors: David Yee, Dag Reppen
  • Publication number: 20040011056
    Abstract: The present additional control strategy has been developed to allow the gas turbine to operate at lower load or at other conditions where the total fuel required by the gas turbine is not optimum for full combustion of the fuel. The present invention manages air that bypasses the catalytic combustor and air that bleeds off of the compressor discharge. The bypass system changes the fuel air ratio of the catalytic combustor without affecting the overall gas turbine power output. The bleed system also changes the fuel air ratio of the catalytic combustor but at the cost of reducing the overall gas turbine efficiency. The key advantage of a catalytic combustor with a bypass and bleed system and the inventive control strategy is that it can maintain the catalyst at optimum low emissions operating conditions over a wider load range than a catalytic combustor without such a system.
    Type: Application
    Filed: February 7, 2002
    Publication date: January 22, 2004
    Inventors: David Yee, Robert Anthony Corr, Sarento George Nickolas
  • Patent number: 5514370
    Abstract: This invention provides pharmaceutical compositions for topical application containing high concentrations of the enzyme collagenase in non-aqueous excipients. The invention also provides a particular excipient, dextran, which is especially useful for admixture with collagenase and which can also be used to advantage with other pharmaceutically active materials.
    Type: Grant
    Filed: November 7, 1994
    Date of Patent: May 7, 1996
    Assignee: Advance Biofactures of Curacao, N.V.
    Inventors: Harold Stern, David Yee
  • Patent number: 5422103
    Abstract: This invention provides pharmaceutical compositions for topical application containing high concentrations of the enzyme collagenase in non-aqueous excipients. The invention also provides a particular excipient, dextran, which is especially useful for admixture with collagenase and which can also be used to advantage with othr pharmaceutically active materials.
    Type: Grant
    Filed: November 24, 1993
    Date of Patent: June 6, 1995
    Assignee: Advance Biofactures of Curacao, N.V.
    Inventors: Harold Stern, David Yee
  • Patent number: 5393792
    Abstract: High concentrations of collagenase as active ingredient in non-aqueous topical pharmaceutical formulations.
    Type: Grant
    Filed: October 29, 1992
    Date of Patent: February 28, 1995
    Assignee: Advance Biofactures of Curacao, N.V.
    Inventors: Harold Stern, David Yee